1. Home
  2. UVE vs EVMN Comparison

UVE vs EVMN Comparison

Compare UVE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

N/A

Current Price

$34.86

Market Cap

925.9M

Sector

Finance

ML Signal

N/A

EVMN

Evommune Inc.

N/A

Current Price

$21.01

Market Cap

892.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UVE
EVMN
Founded
1990
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
925.9M
892.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UVE
EVMN
Price
$34.86
$21.01
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$40.00
$43.29
AVG Volume (30 Days)
199.0K
267.7K
Earning Date
04-23-2026
03-05-2026
Dividend Yield
2.32%
N/A
EPS Growth
214.43
N/A
EPS
6.32
N/A
Revenue
$1,603,915,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.88
N/A
P/E Ratio
$5.24
N/A
Revenue Growth
5.48
N/A
52 Week Low
$20.83
$13.89
52 Week High
$36.68
$33.20

Technical Indicators

Market Signals
Indicator
UVE
EVMN
Relative Strength Index (RSI) 58.11 40.26
Support Level $30.42 $15.25
Resistance Level $35.62 $23.08
Average True Range (ATR) 0.94 2.06
MACD -0.16 -0.42
Stochastic Oscillator 59.19 5.69

Price Performance

Historical Comparison
UVE
EVMN

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: